跳至主要内容
临床试验/NCT06351696
NCT06351696Unknown不适用

The Effects of Low FODMAP Diets Accompanied With and Without Bromelain Supplement on Quality of Life, Disease Activity Index and Inflammation in Patients With Ulcerative Colitis With and Without Primary Sclerosis Cholangitis

National Nutrition and Food Technology Institute2 个研究点 分布在 2 个国家目标入组 84 人开始时间: 2024年4月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
84
试验地点
2
主要终点
SCCAIQ

研究概览

简要总结

In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks.

IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • active mild to moderate UC
  • no other chronic disorders

排除标准

  • changed the type and dosage of their medication in the last month
  • those who have relapses that required hospitalization and change the type and dosage of medications during the intervention
  • patients who do not want to continue the study protocol

结局指标

主要结局

SCCAIQ

时间窗: At the 1st day and 8th week

Simple clinical colitis activity index questionnaire (0-19, higher scores means higher symptoms)

次要结局

  • Serum TNF-a(At the 1st day and 8th week)
  • IBDQ(At the 1st day and 8th week)
  • Serum hsCRP(At the 1st day and 8th week)
  • Serum TAC(At the 1st day and 8th week)

研究者

发起方
National Nutrition and Food Technology Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Azita Hekmatdoost

Principle Investigator

National Nutrition and Food Technology Institute

研究点 (2)

Loading locations...

相似试验